RE:RE:RE:THTX for retail investorsI believe everyone should consider their exit plan based on their overall wealth, risk tolerance and size of their positions in their portfolio.
I personally will assess my exit plan for THTX based on the results of their progresses, if results are promising whether it's oncology early results or NASH getting fast track, breakthrough, priority review or accelerated approval designations I will stay put because in my opinion the market opportunities for those indications are great putting it mildly also those opportunities have not been ascribed to the company's current valuation.
Unless the SP rise significantly probably even higher than your highest predictions on the back of good early results I might consider to sell a portion of my heavily overweight position and keep a rather smaller position as a long term investment but that is just my exit plan.